1Schinazi RF,Sommadossi JP,Thomas H. Therapies for viral Hepatitis [ M ]. London : International Medical Press, 1998,139-145.
2Stuyver L,DeGendt S. VanGeyt C,et al. A new genotype of hepatitis B virus eomplete genome and phylogenetie relatedness[ J]. Jgen Virol , 2000,81 : 67-74.
3Lanford RE, Kim YH, Lee H, et al. Maping of the hepatitis Bvirus reverse transcriptase Tp and RT domains by transcomplementation for nucleotide priming and by protein-protein interaction [ J ]. J Virol, 1999,73 : 1885-1893.
4Lieven J, Stuyver PH, Steohen A, et al. Nomenclature for antiviralresistant human hepatitis B virus mutations in the ploymerase region [J]. Hepatology,2001,33 :751-757.
5Locarnini S, Birch C. Antiviral chemotherapy for chronic hepatitis Binfection :lessons learned from treating HIV-infected patients [ J ]. J Hepatol, 1999,30 : 536 -550.
6Auna SL,Munira H,Carmela C,et al. Evolution of hepatitis B virus polymerase gene mutation in hepatitis B e antigen-nagative patients receiving lamivudine therapy [ J ]. Hepatology, 2000,32 : 1145-1153.
7Allen MI, Deslauriers M, Andrews CW, et al. Indetifieation and characterization of mutations in hepatitis B virus resistant to lamivudine. lamivudine clinical investigation Group[ J]. Hepatology, 1998,27 : 1670-1677.
8Ono-Nita SK, Kato N, Shiratori Y,et al. Susceptibility of lamivudineresistant hepatitis B virus to other reverstranscriptase inhibitors. J Clin Invest, 1999,103 : 1635-1640.
9Akuta N, Tsubota A, Suzuki F,et al. Long-term prognosis by lamivudine monotherapy for severe acute exacerbation in chronic hepatitis B infection: emergence of YMDD motif mutant and risk of breakthrough hepatitis - an open-cohort study [ J ]. J Hepatol, 2003,38 (1):91-97.
10Shin YM, Cho M, Heo J,et al. Natural YMDD Motif Mutations of HBV Polymerase in the Chronic Hepatitis B Virus Infected Patients [ J ]. Taehan Kan Hakhoe Chi, 2003, 9 ( 1 ) : 1-9.
同被引文献21
1Dong-Yao Zhou,Yong-Jian Cao,Lian-Ying Lin,Hong Wang,Jian-Sheng Huang the Department of Clinical Laboratory Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou 510120, China Institution of Molecular Biology Diagnostic Center, First Military Medical University, Guangzhou 510515, China.HBV resistant to lamivudine: experimental and clinical studies[J].Hepatobiliary & Pancreatic Diseases International,2002,1(4):519-522. 被引量：3
